hGRB14(2)

Nomenclature

C57BL/6JSmo-Grb14tm1(hGRB14)Smoc

Cat. NO.

NM-HU-251628

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Grb14

Model Description

The endogenous mouse Grb14 gene was replaced by human GRB14 gene.

Validation Data

image.png

Fig.1 Detection of GRB14 expression in heart and liver by RT-PCR. Mouse Grb14 mRNA (225 bp) was detectable both in wild-type C57BL/6 mice and heterozygous hGRB14(2) knock-in mice. Human GRB14 mRNA (442 bp/872 bp/869 bp/396 bp/346 bp) was detectable only in heterozygous hGRB14(2) knock-in mice but not in wild-type mice. Heart and liver RNA was extracted from 8-week-old male wild-type C57BL/6 (WT)(n=2) and heterozygous hGRB14(2) knock-in mice (HE) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HE, heterozygous; WT, wild type.

image.png

Fig.2 Detection of GRB14 expression in hGRB14(2) mice by WB. GRB14 was detectable in the liver from both WT C57BL/6 and HE hGRB14(2) mice, as the antibody was cross-reactived between human and mouse GRB14.  The liver lysates were collected from 8-week-old male wild-type C57BL/6 mice and 8-week-old male heterozygous hGRB14(2) mice, and then analyzed by western blot with anti-GRB14 antibody. 

Abbr. HE, heterozygous; WT, wild type; PC, positive control, PC1, HepG2 cells, PC2, HT-1080 cells; M, marker.

image.png

Fig.3 Detection of GRB14 expression in hGRB14(2) mice by WB. GRB14 was detectable in heart and small intestine tissues from both WT C57BL/6 and HE hGRB14(2) mice, as the antibody was cross-reactived between human and mouse GRB14. The heart and small intestine lysates were collected from 8-week-old male wild-type C57BL/6 mice and 8-week-old male heterozygous hGRB14(2) mice, and then analyzed by western blot with anti-GRB14 antibody. 

Abbr. HE, heterozygous; WT, wild type; PC, positive control, PC1, HepG2 cells, PC2, HT-1080 cells; M, marker.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more